EQL Pharma

Based on the above, the Nomination Committee for the 2026 Annual General Meeting, which will be held in Lund on 20 August 2026, has been determined to consist of:

• Christer Fåhraeus (appointed by Fårö Capital AB),
• Rajiv I Modi (appointed by Cadila Pharmaceuticals Ltd.), and
• Sten Irwe.

The Nomination Committee's proposal will be presented in the notice of the 2026 Annual General Meeting and published on the company's website, www.eqlpharma.com.

The Nomination Committee's tasks include preparing and submitting proposals to the upcoming Annual General Meeting for: election of the Chairman of the Annual General Meeting; election of the Chairman and other members of the Board; board fees divided between the Chairman and other members and any remuneration for committee work; election of the auditor and remuneration to him/her; and principles for the appointment of the Nomination Committee.

Shareholders who wish to submit proposals to the Nomination Committee are encouraged to send an e-mail to info@eqlpharma.com. In order for the proposals to be considered by the Nomination Committee, they must be submitted well in advance of the Annual General Meeting.